Prospective Trial of Rituximab for Primary Pulmonary Alveolar Proteinosis

Clinical trial NCT00552461 · COMPLETED

Trial details

NCT number: NCT00552461
Sponsor: East Carolina University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Alveolar Proteinosis Primary Disease

Start date: 2007-01-01
Primary completion: 2009-07-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.